Mineralys Therapeutics Inc.

MLYS | NASDAQ

Price Alert Chart Builder DCF Calculator

$29.09

+$0.78 (+2.76%)

Sep 22, 2026, 1:37 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q4 2021 Dec 30, 2021
Cash & Equivalents	138.27M	112.78M	172.92M	217.6M	101.79M	165.01M	114.09M	97.27M	67.86M	90.42M	49.3M	86.3M	101.14M	138.25M	87.7M	48.96M	10.61M
Short-Term Investments	523.14M	533.28M	483.71M	n/a	223.13M	178.02M	84.1M	166.33M	243.26M	248.15M	187.26M	167.46M	159.96M	132.39M	22.41M	72M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.48M	12.13M	21.68M	31.12M	n/a	n/a	n/a
Other Long-Term Assets	2.02M	360K	382K	144K	433K	397K	499K	452K	449K	379K	51K	51K	51K	39K	1.63M	564K	3K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	6.41M	4.75M	382.2M	10.35M	11.48M	7.16M	4.13M	6.89M	8.25M	12.54M	n/a	8.39M	4.64M	2.7M	n/a	50K
Total Current Assets	665.8M	652.47M	661.39M	599.8M	335.27M	354.51M	205.35M	267.73M	318M	346.82M	249.1M	265.38M	269.49M	275.27M	112.81M	121.89M	11.12M
Property-Plant & Equipment	27K	32K	38K	7K	22K	38K	53K	69K	42K	51K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.05M	392K	420K	151K	455K	435K	552K	521K	491K	430K	2.53M	12.18M	21.73M	31.16M	1.63M	564K	3K
Total Assets	667.85M	652.86M	661.81M	599.95M	335.72M	354.94M	205.9M	268.25M	318.49M	347.25M	251.64M	277.56M	291.22M	306.44M	114.44M	122.45M	11.13M
Account Payables	1.07M	1.12M	2.02M	1.12M	3.16M	373K	479K	3.11M	1.71M	4.26M	601K	5.57M	2.2M	2.39M	1.91M	2.56M	763K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	11.29M	7.56M	18.52M	2.62M	1.15M	3.58M	2.1M	1.33M	662K	1.6M	6.75M	764K	381K	665K	403K	313K
Total Current Liabilities	19.32M	14.72M	15.11M	23.52M	22.17M	13.39M	14.65M	31.32M	28.4M	19.2M	10.48M	13.54M	6.21M	10.56M	8.07M	7.22M	5.05M
Long-Term Debt	97.62M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	158.64M	158.64M	29M
Total Long-Term Liabilities	97.62M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	158.64M	158.64M	29M
Total Liabilities	116.94M	14.72M	15.11M	23.52M	22.17M	13.39M	14.65M	31.32M	28.4M	19.2M	10.48M	13.54M	6.21M	10.56M	166.71M	165.86M	34.05M
Total Debt	97.62M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Book Value	550.92M	638.14M	646.69M	576.43M	313.55M	341.56M	191.26M	236.93M	290.1M	328.05M	241.15M	264.01M	285.01M	295.88M	-52.27M	-43.41M	-22.93M
Book Value Per Share	6.50	7.70	8.03	8.17	4.79	6.42	3.83	4.76	5.88	7.31	6.01	6.61	7.17	11.95	-10.03	-8.38	-4.45
Common Stock	9K	8K	8K	8K	6K	6K	5K	5K	5K	5K	4K	4K	4K	4K	1K	1K	1K
Retained Earnings	-737.58M	-496.51M	-457.17M	-424.94M	-388M	-344.73M	-302.52M	-253.57M	-197.23M	-156.22M	-124.71M	-100.32M	-77.56M	-65.42M	-52.81M	-43.74M	-23.01M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-251.64M	0	0	n/a	n/a	n/a	n/a
Shareholders Equity	550.92M	638.14M	646.69M	576.43M	313.55M	341.56M	191.26M	236.93M	290.1M	328.05M	241.15M	264.01M	285.01M	295.88M	-52.27M	-43.41M	-22.93M
Total Investments	523.14M	533.28M	483.71M	n/a	223.13M	178.02M	84.1M	166.33M	243.26M	248.15M	189.75M	179.59M	181.64M	163.52M	22.41M	72M	n/a